ClinicalTrials.govpublic full text
Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)
cicatrix, wound healing, re-epithelialization, scar, avotermin, juvista, rn1001, tgf beta 3, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 891745
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.